These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The role of genetic and epigenetic changes in pituitary tumorigenesis. Fukuoka H; Takahashi Y Neurol Med Chir (Tokyo); 2014; 54(12):943-57. PubMed ID: 25446387 [TBL] [Abstract][Full Text] [Related]
46. Genetic Testing in Hereditary Pituitary Tumors. Akkuş G; Korbonits M Arch Med Res; 2023 Dec; 54(8):102920. PubMed ID: 38007383 [TBL] [Abstract][Full Text] [Related]
47. An update on the genetics of benign pituitary adenomas in children and adolescents. Hannah-Shmouni F; Stratakis CA Curr Opin Endocr Metab Res; 2018 Aug; 1():19-24. PubMed ID: 30555957 [TBL] [Abstract][Full Text] [Related]
49. Genetic factors in the development of pituitary adenomas. Vandeva S; Tichomirowa MA; Zacharieva S; Daly AF; Beckers A Endocr Dev; 2010; 17():121-133. PubMed ID: 19955762 [TBL] [Abstract][Full Text] [Related]
50. [Tumor predisposition in endocrinology - from MEN to FIPA]. Jegodzinski L; Gebauer J Dtsch Med Wochenschr; 2024 Mar; 149(6):283-289. PubMed ID: 38412983 [TBL] [Abstract][Full Text] [Related]
51. Craniopharyngioma: modern concepts in pathogenesis and treatment. Garrè ML; Cama A Curr Opin Pediatr; 2007 Aug; 19(4):471-9. PubMed ID: 17630614 [TBL] [Abstract][Full Text] [Related]
52. [Practice guideline for diagnosis and treatment of craniopharyngioma and parasellar tumors of the pituitary gland]. Venegas E; Concepcion B; Martin T; Soto A; Endocrinol Nutr; 2015 Jan; 62(1):e1-13. PubMed ID: 25066506 [TBL] [Abstract][Full Text] [Related]
54. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000. Müller HL; Gebhardt U; Etavard-Gorris N; Kolb R; Warmuth-Metz M; Sörensen N Onkologie; 2005 Mar; 28(3):150-6. PubMed ID: 15772466 [TBL] [Abstract][Full Text] [Related]
55. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy. Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526 [TBL] [Abstract][Full Text] [Related]
56. Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome. Dötsch J; Kiess W; Hänze J; Repp R; Lüdecke D; Blum WF; Rascher W J Clin Endocrinol Metab; 1996 Nov; 81(11):3839-42. PubMed ID: 8923825 [No Abstract] [Full Text] [Related]
57. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature]. Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897 [TBL] [Abstract][Full Text] [Related]
58. The causes and consequences of pituitary gigantism. Beckers A; Petrossians P; Hanson J; Daly AF Nat Rev Endocrinol; 2018 Dec; 14(12):705-720. PubMed ID: 30361628 [TBL] [Abstract][Full Text] [Related]
59. [Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas]. Vacchiano V; Seleme S; Daly AF; Beckers A; Valdés-Socin H Medicina (B Aires); 2020; 80(2):181-184. PubMed ID: 32282328 [TBL] [Abstract][Full Text] [Related]